Adbry 150 mg/mL prefilled syringe Images

Generic Name: tralokinumab

This medication has been identified as Adbry 150 mg/mL prefilled syringe. It is supplied by LEO Pharma Inc.

Adbry is used in the treatment of Atopic Dermatitis and belongs to the drug class interleukin inhibitors. Adbry 150 mg/mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Adbry

Generic Name

tralokinumab

Strength

150 mg/mL prefilled syringe

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

LEO Pharma Inc.

National Drug Code (NDC)

50222-0346

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer